News
Chardan Capital Maintains Buy on Achilles Therapeutics, Lowers Price Target to $6
5 Apr 24
News, Price Target, Analyst Ratings
Piper Sandler Downgrades Achilles Therapeutics to Neutral, Lowers Price Target to $2
5 Apr 24
News, Downgrades, Price Target, Analyst Ratings
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
4 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
4 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's Intraday Session
4 Apr 24
Movers
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
4 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
12 Health Care Stocks Moving In Thursday's Pre-Market Session
4 Apr 24
Movers
Achilles Therapeutics Q4 EPS $(0.46) May Not Be Comparable To $(0.14) Estimate, Cash Position Of $131.5M Supports Operations Through 2025
4 Apr 24
Earnings, News
Achilles Therapeutics Provides Interim Phase 1/2a Update on Clonal Neoantigen Reactive T Cells In Advanced NSCLC And Melanoma Including First Patients Dosed with Enhanced Host Conditioning
4 Apr 24
Biotech, News, Health Care, General
Press releases
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
22 May 24
Health Care, Press Releases
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
17 May 24
Press Releases
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
8 May 24
Earnings, Press Releases
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
4 Apr 24
Earnings, Press Releases
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
4 Apr 24
Health Care, Press Releases